Identifying squalene epoxidase as a metabolic vulnerability in high-risk osteosarcoma using an artificial intelligence-derived prognostic index.
Yongjie WangXiaolong MaEnjie XuZhen HuangChen YangKun-Peng ZhuYang DongChun-Lin ZhangPublished in: Clinical and translational medicine (2024)
AIDPI is a robust biomarker for identifying the high-risk subset of OSA patients. The SQLE protein emerges as a metabolic vulnerability in these patients, providing a target with translational potential.